Johannes Roth - Promis Neurosciences Independent Director
| 23J Stock | EUR 10.90 2.50 18.66% |
Director
Mr. Johannes Minho Roth is a Independent Director of ProMIS Neurosciences Inc. Mr. Roth is the founding director and partner at FiveT Capital Holding AG, a PfffikonSwitzerlandbased innovative financial holdings firm with activities in quantitative tailored investment and risk management solutions for institutional investors and high networth individuals with sophisticated wealth management, investment and risk requirements. He has many years of experience as a CIO and portfolio manager for FiveT Capital AG and as an equity specialist and proprietary trader at Baaderbank AG since 2013.
| Age | 40 |
| Tenure | 13 years |
| Address | 1920 Yonge Street, Toronto, ON, Canada, M4S 3E2 |
| Phone | 416 847 6898 |
| Web | https://www.promisneurosciences.com |
Promis Neurosciences Management Efficiency
The company has return on total asset (ROA) of (0.8538) % which means that it has lost $0.8538 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.558) %, meaning that it generated substantial loss on money invested by shareholders. Promis Neurosciences' management efficiency ratios could be used to measure how well Promis Neurosciences manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Promis Neurosciences' Total Current Assets are most likely to increase significantly in the upcoming years. The Promis Neurosciences' current Intangible Assets is estimated to increase to about 44 K, while Other Current Assets are projected to decrease to roughly 30.3 K.Similar Executives
| Found 9 records | DIRECTOR Age | ||
| AICPA BA | Transport International Holding | N/A | |
| BSc CEng | Transport International Holding | 63 | |
| Owen Eckford | Transport International Holding | N/A | |
| Michael Armstrong | JD SPORTS FASH | N/A | |
| BSc BSc | Transport International Holding | 60 | |
| HKIA BArch | Transport International Holding | 58 | |
| Dominic Platt | JD SPORTS FASH | 57 | |
| George Mersho | JD SPORTS FASH | N/A | |
| Chun Hui | Transport International Holding | 61 | |
Management Performance
| Return On Equity | -3.56 | ||||
| Return On Asset | -0.85 |
Promis Neurosciences Leadership Team
Elected by the shareholders, the Promis Neurosciences' board of directors comprises two types of representatives: Promis Neurosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Promis. The board's role is to monitor Promis Neurosciences' management team and ensure that shareholders' interests are well served. Promis Neurosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Promis Neurosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Elliot Goldstein, President, Chief Executive Officer, Director | ||
| Anthony Giovinazzo, Independent Director | ||
| Johanne Kaplan, Chief Development Officer | ||
| Daniel Geffken, Chief Financial Officer | ||
| Neil MD, CoChairman CoFounder | ||
| James Kupiec, Chief Medical Officer | ||
| David Wishart, Chief Officer | ||
| Neil Cashman, Co-Founder, Chief Scientific Officer, Director | ||
| Johannes Roth, Independent Director | ||
| Larry MD, Chief Officer | ||
| Daniel MBA, Chief Officer | ||
| Robert Gundel, Director | ||
| Dennis Chen, Head Consultant | ||
| Eugene Williams, Executive Chairman of the Board | ||
| Steven Plotkin, Chief Physics Officer | ||
| Richard Gregory, Independent Director | ||
| William Wyman, Independent Director | ||
| Patrick Kirwin, Independent Director | ||
| Neil MBA, President CEO |
Promis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Promis Neurosciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.56 | ||||
| Return On Asset | -0.85 | ||||
| Current Valuation | 10.82 M | ||||
| Shares Outstanding | 7.2 M | ||||
| Shares Owned By Insiders | 24.60 % | ||||
| Shares Owned By Institutions | 18.42 % | ||||
| Price To Book | 3.70 X | ||||
| Price To Sales | 4,159 X | ||||
| Gross Profit | (28.34 M) | ||||
| EBITDA | (14.02 M) |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Promis Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more detail on how to invest in Promis Stock please use our How to Invest in Promis Neurosciences guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.